MARKETSANDMARKETS NEXT - GEN IMMUNO ONCOLOGY CONFERENCE


Transforming cancer care through innovative immunotherapies


5TH -6TH OCTOBER 2023
FRANKFURT, GERMANY
5TH -6TH OCTOBER 2023 | FRANKFURT, GERMANY
Transforming cancer care through innovative immunotherapies
5TH -6TH OCTOBER 2023
FRANKFURT, GERMANY
5TH -6TH OCTOBER 2023 | FRANKFURT, GERMANY
Our MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 5th – 6th October 2023, in Frankfurt, would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors.
to be held on 5th -6th October 2023 | Frankfurt, Germany
This conference will highlight the current state of immuno-oncology for cancer care professionals with emphasis on current research, utilization trends, and advances in immunotherapies. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, biopharma and biotech companies, the congress will discuss the latest updates in development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy
Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you.
Explore the latest platforms and technologies on the market for development.
Discuss the best tool for your research in immune oncology.
Share your work and achievements with your industry peers in the Poster Sessions
Academics:
From Pharmaceutical, Biopharmaceutical and Research institutes. CSO, Director, VP, Head, Senior Investigator, Manager, Principal Scientist, Team Leader, Group leaders, Professor, Assistant professors, Research fellow, PhD working on
and Bispecific Antibodies Cell Therapy Immune Checkpoint Inhibitors
• ADCs development Preclinical and Translational Oncology
• Oncology
• Bi-specifics- Preclinical and Translational
• Clinical development
• R&D- Discovery and process
• PKPD/ADME/Tox
• Antibody Engineering
• Antibody therapeutics
• Physio-Chemistry /Synthetic Chemistry and/ Bio conjugation
• Bioanalysis
• Oncology
• Clinical development
• T cell therapy
• CAR-T cell therapy
• R&D- discovery and process
• Therapeutic areas
• PKPD/ADME/Tox
• Biologics -antibody
• Cell-Based Immunotherapies
• Innate and adaptive immune cells
• Antibody engineering
• Tumour antigens and neoantigens
• Cancer immunotherapy
• Immune checkpoint targets
• Checkpoint inhibition
• Cellular therapy
• Clinical research
• Combination therapy
• Cancer Vaccines
• Preclinical and Translational Oncology R&D
• Immune biomarkers
• Immunology
• Cancer biology
• Immuno-oncology
• Tumour-associated mechanisms of immune suppression
Pier Francesco Ferrucci Director, Tumour Biotherapy Unit European Institute of Oncology, Italy
Ralph Graeser Head Translational Medicine Immune Oncology
Pieris Pharmaceuticals, Germany
Sonia Maciá
Executive Medical Director LAVA Therapeutics, Spain
Ivan Diaz-Padilla Vice-President, Oncology Clinical Development
GSK, Switzerland
Christoph Huber
Chairman Board of Directors, Association for Cancer Immunotherapy CIMT Germany
Vaios Karanikas Biomarker Experimental Medicine Leader, Oncology, Roche Switzerland
Ariel Marcotegui Medical Science Liaison – Oncology Amgen, Spain
Philip Beer Chief Scientific Officer Step Pharma, UK
Senior Representative Revvity Inc, USA
MarketsandMarkets Events is a wholly owned division of MarketsandMarkets a global market research and intelligence company producing over 1200 premium market research reports every year across 12 different industry verticals. By bringing together expert speakers from across the world and leading technology and service providers Events provide a senior level educational and networking platform where knowledge is shared and partnerships and collaborations can be formed. With offices in Asia Europe and USA MarketsandMarkets ensures a truly global attendance at every event where attendees speakers exhibitors and sponsors can exchange ideas in a relaxed and professional environment.
+91 20 48598 285 | +44 (0)1865-842-976
events@marketsandmarkets.com
www.marketsandmarkets.com